All posts by: Michael Zand

About Michael Zand

Stem cells to cure life threatening illnesses [Sci Tech] – africanews

Continue reading

2018-05-08 NEWS

africanews

Stem cells to cure life threatening illnesses [Sci Tech]
africanews
When harvested and re-injected into humans, the stem cells help re-grow and regenerate cells that were damaged or lost due to illness and injury. Also, we tell you why news about three black girls in the United States named among finalists for NASA’s
AGU concludes Stem Cell ConferenceBahrain News Agency
Fasting may boost stem cell regeneration, says studyInformation-Analytic Agency NEWS.am

all 27 news articles »

Continue reading

2018-05-08 NEWS

Phys.Org

CRISPR-guided proximity labeling—dissecting gene transcription’s …
Phys.Org
More powerful than previous methods, a new approach for tagging and harvesting DNA-associated proteins from cells could open deeper insights into …
New CRISPR technology ‘knocks out’ yeast genes with single-point …Science Daily
Researchers modify CRISPR to knock out single genes in yeastNews-Medical.net

all 3 news articles »

Continue reading

2018-05-08 NEWS

Mass Device

OncoSec to combine ImmunoPulse device with Merck’s immunotherapy in breast cancer trial
Mass Device
OncoSec Medical (NSDQ:ONCS) expanded its relationship with Merck (NYSE:MRK) today, announcing a deal to combine its ImmunoPulse IL-12 device with Merck’s anti-PD-1 therapy, Keytruda, in a Phase II trial of patients with triple negative breast cancer

Continue reading

2018-05-08 NEWS

Post Analyst

CRISPR Therapeutics Provides Business Update and Reports First Quarter 2018 Financial Results
GlobeNewswire (press release)
ZUG, Switzerland and CAMBRIDGE, Mass., May 08, 2018 (GLOBE NEWSWIRE) — CRISPR Therapeutics (NASDAQ:CRSP), a biopharmaceutical company focused on developing transformative gene-based medicines for serious diseases, today provided a business update and
Investors Jumping Ship on Skechers USA, Inc. (SKX), CRISPR Therapeutics AG (CRSP)Post Analyst
The Market’s 4 Best Stocks to Buy Right NowYahoo Finance

all 74 news articles »